Literature DB >> 17853024

Myosin heavy-chain isoform distribution, fibre-type composition and fibre size in skeletal muscle of patients on haemodialysis.

Stig Molsted1, Inge Eidemak, Helle Tauby Sorensen, Jens Halkjaer Kristensen, Adrian Harrison, Jesper L Andersen.   

Abstract

OBJECTIVE: Chronic uraemia is associated with abnormalities in skeletal muscles, which can affect their working capacity. It is also well known that the fibre-type composition of skeletal muscles influences endurance, muscle strength and power. In this study we therefore determined the size and distribution of muscle fibres and the myosin heavy-chain (MHC) isoform composition in patients on haemodialysis (HD) in order to establish any differences with values for untrained control subjects.
MATERIAL AND METHODS: Muscle biopsies were obtained from the vastus lateralis muscle of 14 non-diabetic patients on HD. The size and distribution of muscle fibres were evaluated using adenosine triphosphate synthase (ATPase) histochemistry, whilst MHC isoform composition was determined in muscle homogenates using sodium dodecyl sulphate-polyacrylamide gel electrophoresis. Values were compared to those for a group of age-, gender- and BMI-matched untrained control subjects. The aerobic work capacity of the patients was also determined.
RESULTS: The MHC composition for I, IIA and IIX isoforms was found to be 35.3% +/- 18.2%, 35.9% +/- 7.1% and 28.9% +/- 15.6%, respectively, findings supported by the ATPase histochemically determined fibre-type composition of the vastus lateralis muscle. The mean fibre area of type 1 and 2 fibres was 3283 +/- 873 and 3594 +/- 1483 MICROm2, respectively. The MHC composition and the size of the type 1 fibres of the patients on HD were significantly different from those of the control subjects.
CONCLUSIONS: The data demonstrate relatively fewer type 1 and consequently more type 2x fibres, with a corresponding change in MHC isoforms (MHC I and MHC IIX) in the skeletal muscle of patients on HD. Several patients on HD were found to have <15% type 1 (or relative percentage of MHC I) fibres. Such a low percentage of type 1 fibres is very rarely observed in normal untrained subjects. Chronic uraemia more severely affects the composition than the size of fibres.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17853024     DOI: 10.1080/00365590701421330

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  6 in total

Review 1.  [Exercise and cellular adaptation of muscle].

Authors:  U Tegtbur; M W Busse; H P Kubis
Journal:  Unfallchirurg       Date:  2009-04       Impact factor: 1.000

2.  Metabolic and morphometric profile of muscle fibers in chronic hemodialysis patients.

Authors:  Michael I Lewis; Mario Fournier; Huiyuan Wang; Thomas W Storer; Richard Casaburi; Arthur H Cohen; Joel D Kopple
Journal:  J Appl Physiol (1985)       Date:  2011-10-20

Review 3.  [What is currently available for sport medicine therapy?]

Authors:  U Tegtbur
Journal:  Internist (Berl)       Date:  2016-12       Impact factor: 0.743

Review 4.  Morphological, electrophysiological, and metabolic characteristics of skeletal muscle in people with end-stage renal disease: a critical review.

Authors:  Anuradha Sawant; S Jayne Garland; Andrew A House; Tom J Overend
Journal:  Physiother Can       Date:  2011-08-10       Impact factor: 1.037

5.  Blood flow-restricted strength training displays high functional and biological efficacy in women: a within-subject comparison with high-load strength training.

Authors:  Stian Ellefsen; Daniel Hammarström; Tor A Strand; Erika Zacharoff; Jon E Whist; Irene Rauk; Håvard Nygaard; Geir Vegge; Marita Hanestadhaugen; Mathias Wernbom; Kristoffer T Cumming; Roar Rønning; Truls Raastad; Bent R Rønnestad
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-07-22       Impact factor: 3.619

6.  Reduced skeletal muscle function is associated with decreased fiber cross-sectional area in the Cy/+ rat model of progressive kidney disease.

Authors:  Jason M Organ; Andrew Srisuwananukorn; Paige Price; Jeffery E Joll; Kelly C Biro; Joseph E Rupert; Neal X Chen; Keith G Avin; Sharon M Moe; Matthew R Allen
Journal:  Nephrol Dial Transplant       Date:  2015-10-05       Impact factor: 5.992

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.